SpaceX Stock: Is It a Buy at $150?

SpaceX (NASDAQ: SPCX) is back around the ~$150 level after sliding from nearly $226 at its IPO, with trading volumes dropping materially since the initial rush. Despite the price pullback, the article flags the valuation as still extreme at ~110x trailing revenue for an unprofitable business. Overall, fading IPO excitement and valuation concerns suggest downside risk and that the stock may not be a compelling buy near-term.

Analysis

This is more a marginal-buyer problem than a business-model problem: once the initial post-listing flow fades, a name with no earnings anchor can reprice very quickly because there is no hard floor from free cash flow. At roughly 100x+ trailing sales, even a modest reset in the acceptable duration multiple can produce another 30-50% downside without any change in the operating story. The key mechanism is that attention is a financing input here; when attention decays, so does the market’s willingness to capitalize distant optionality.

The second-order implication is broader than one stock. If this de-rates cleanly, it becomes a warning shot for other venture-style listings and long-dated “story” equity where the public market is being asked to underwrite milestones years out; that can tighten terms for late-stage private rounds and slow IPO windows for months. Space/AI-adjacent public comps with similar scarcity premiums are the most vulnerable to multiple compression if investors start demanding nearer-term monetization.

Contrarian view: the selloff could be overdone tactically if the float is still small and the stock becomes mechanically oversold, but that is a trading bounce, not a fundamental reset. What would falsify the bearish thesis is verifiable evidence of accelerating backlog conversion, a credible path to positive operating cash flow, or strategic capital that materially de-risks dilution. Absent that, the base case is continued multiple compression over the next 1-3 months, with the structural re-rate likely taking 6-18 months.

Key Decisions for Investors

• Avoid initiating new long exposure in SPCX until there is one clean quarterly filing that shows backlog conversion and burn discipline; treat any current strength as a liquidity event, not a valuation reset.
• If SPCX borrow/liquidity is workable, consider a small tactical short on a 10-15% relief rally from current levels, targeting a retest of post-IPO lows over 1-3 months; stop on a credible strategic financing or materially better operating disclosure.
• Use the de-rating as a warning signal to trim exposure to other pre-profit, narrative-driven IPOs and space-beta names (e.g., RKLB/ASTS/LUNR) where the market is paying for optionality rather than cash flow.
• Set an alert for any disclosure that changes the financing path: new capital raise, lockup-style supply overhang, or a step-up in public-market sponsorship; that is the most likely catalyst to reverse the current trend.